Sam Thorley serves as the Commercial Operations and Strategy Lead at RayzeBio since July 2025, focusing on building teams for the global delivery of actinium-based radiopharmaceuticals. Prior to this role, Sam held several key positions at Bristol Myers Squibb from June 2014 to July 2025, including Vice President of Cell Therapy Cross-Functional Operations, where leadership was provided to a 175+ member global team and initiatives for efficiency and scalability in patient care were implemented. Significant contributions included overseeing a cell therapy transformation initiative, leading commercialization strategies, and successfully launching various oncology products. Sam earned an MBA from the UNC Kenan-Flagler Business School, building on a Bachelor of Science in Sociology from Brigham Young University. Experience also includes a tenure as a Uniform Sales Representative at Cintas and as a Sales Consultant at Prosper.
This person is not in the org chart
This person is not in any teams
This person is not in any offices